PHS
PFM Health Sciences Portfolio holdings
AUM
$1.15B
This Quarter Return
+10.41%
1 Year Return
+21.39%
3 Year Return
+130.75%
5 Year Return
+265.32%
10 Year Return
+1,236.5%
AUM
$2.49B
AUM Growth
+$2.49B
(+15%)
Cap. Flow
+$216M
Cap. Flow
% of AUM
8.7%
Top 10 Holdings %
Top 10 Hldgs %
34.88%
Holding
90
New
15
Increased
23
Reduced
16
Closed
9
Top Buys
| 1 |
Biogen
BIIB
|
$56.5M |
| 2 |
Stryker
SYK
|
$41.2M |
| 3 |
Icon
ICLR
|
$37.3M |
| 4 |
Alkermes
ALKS
|
$36M |
| 5 |
AbbVie
ABBV
|
$29M |
Top Sells
| 1 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
$35.7M |
| 2 |
Avantor
AVTR
|
$28.6M |
| 3 |
uniQure
QURE
|
$23.5M |
| 4 |
Ascendis Pharma
ASND
|
$21.7M |
| 5 |
ICU Medical
ICUI
|
$20.2M |
Sector Composition
| 1 | Healthcare | 98.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Eli Lilly
LLY
$657B
| $140M | 5.44% | 298,643 | – | – |
|
2
Penumbra
PEN
$10.6B
| $124M | 4.81% | 360,030 | – | – |
|
|
HZNP
3
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $112M | 4.36% | 1,091,840 | – | – |
|
4
Cytokinetics
CYTK
$4.23B
| $78.3M | 3.04% | 2,399,545 | – | – |
|
5
Centene
CNC
$14.3B
| $75M | 2.91% | 1,112,480 | – | – |
|
6
Humana
HUM
$36.5B
| $74.3M | 2.88% | 166,066 | – | – |
|
7
Merck
MRK
$210B
| $68.8M | 2.67% | 596,261 +135,143 | +29% | +$15.6M |
|
|
8
AbbVie
ABBV
$372B
| $68M | 2.64% | 504,498 +215,595 | +75% | +$29M |
|
9
Edwards Lifesciences
EW
$47.8B
| $66.3M | 2.57% | 702,588 +53,955 | +8% | +$5.09M |
|
10
Cardinal Health
CAH
$35.5B
| $60.5M | 2.35% | 639,783 | – | – |
|
11
Intuitive Surgical
ISRG
$170B
| $58.8M | 2.28% | 172,043 -6,820 | -4% | -$2.33M |
|
|
12
Biogen
BIIB
$19.4B
| $56.5M | 2.19% | +198,334 | New | +$56.5M |
|
13
UnitedHealth
UNH
$281B
| $55.8M | 2.17% | 116,067 | – | – |
|
|
14
Icon
ICLR
$13.8B
| $53.4M | 2.07% | 213,559 +149,142 | +232% | +$37.3M |
|
15
Prothena Corp
PRTA
$441M
| $52.9M | 2.05% | 774,546 | – | – |
|
16
iRhythm Technologies
IRTC
$5.46B
| $50.6M | 1.97% | 485,468 | – | – |
|
|
SGEN
17
DELISTED
Seagen Inc. Common Stock
SGEN
| $49.3M | 1.92% | 256,299 +35,416 | +16% | +$6.82M |
|
18
HCA Healthcare
HCA
$94.5B
| $48.2M | 1.87% | 158,772 +10,272 | +7% | +$3.12M |
|
19
DexCom
DXCM
$29.5B
| $48.1M | 1.87% | 374,478 -49,338 | -12% | -$6.34M |
|
20
Legend Biotech
LEGN
$6.41B
| $46.9M | 1.82% | 679,076 +206,915 | +44% | +$14.3M |
|
21
Syndax Pharmaceuticals
SNDX
$1.41B
| $45.5M | 1.77% | 2,172,437 +225,785 | +12% | +$4.73M |
|
22
McKesson
MCK
$85.4B
| $45.2M | 1.76% | 105,811 | – | – |
|
23
IQVIA
IQV
$32.4B
| $45.2M | 1.75% | 201,037 | – | – |
|
24
Universal Health Services
UHS
$11.6B
| $44.7M | 1.74% | 283,257 +49,572 | +21% | +$7.82M |
|
25
Molina Healthcare
MOH
$9.8B
| $43.3M | 1.68% | 143,779 | – | – |
|